It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AGL’s FA Score shows that 0 FA rating(s) are green whileJXFGF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AGL’s TA Score shows that 4 TA indicator(s) are bullish.
AGL (@Medical/Nursing Services) experienced а -38.71% price change this week, while JXFGF (@Medical/Nursing Services) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -4.80%. For the same industry, the average monthly price growth was -4.08%, and the average quarterly price growth was +1669.16%.
AGL is expected to report earnings on Feb 26, 2025.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
AGL | JXFGF | AGL / JXFGF | |
Capitalization | 2.5B | 1.57B | 159% |
EBITDA | -167.64M | 648M | -26% |
Gain YTD | -86.375 | -71.498 | 121% |
P/E Ratio | N/A | 100.00 | - |
Revenue | 4.32B | 1.84B | 235% |
Total Cash | 488M | 1.93B | 25% |
Total Debt | 49.5M | 2.09B | 2% |
AGL | |
---|---|
RSI ODDS (%) | 3 days ago70% |
Stochastic ODDS (%) | 3 days ago75% |
Momentum ODDS (%) | 3 days ago88% |
MACD ODDS (%) | 3 days ago81% |
TrendWeek ODDS (%) | 3 days ago85% |
TrendMonth ODDS (%) | 3 days ago86% |
Advances ODDS (%) | 11 days ago0% |
Declines ODDS (%) | 9 days ago0% |
BollingerBands ODDS (%) | 3 days ago68% |
Aroon ODDS (%) | 3 days ago84% |
A.I.dvisor indicates that over the last year, AGL has been loosely correlated with ASTH. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AGL jumps, then ASTH could also see price increases.
Ticker / NAME | Correlation To AGL | 1D Price Change % | ||
---|---|---|---|---|
AGL | 100% | -9.04% | ||
ASTH - AGL | 51% Loosely correlated | -0.02% | ||
AMN - AGL | 47% Loosely correlated | -2.97% | ||
CCRN - AGL | 43% Loosely correlated | -0.89% | ||
USPH - AGL | 29% Poorly correlated | -1.84% | ||
SGRY - AGL | 29% Poorly correlated | -2.88% | ||
More |
A.I.dvisor tells us that JXFGF and AGL have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JXFGF and AGL's prices will move in lockstep.
Ticker / NAME | Correlation To JXFGF | 1D Price Change % | ||
---|---|---|---|---|
JXFGF | 100% | N/A | ||
AGL - JXFGF | 4% Poorly correlated | -9.04% | ||
AVAH - JXFGF | 2% Poorly correlated | -4.01% | ||
MCVEF - JXFGF | 0% Poorly correlated | N/A | ||
EVGRF - JXFGF | 0% Poorly correlated | N/A | ||
LTGHF - JXFGF | -1% Poorly correlated | N/A | ||
More |